He et al. in 2025 showed that PaCa cells with mutated KRAS alleles had increased TMOD3 expression, which was found to be dependent on ELK1 activation, as a downstream Ras signaling target [272]. This evidence concerns the gene KRAS and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.